Nanion Introduces New Product Family: CardioExcyte 96 for Cardiac Toxicity Profiling and Screening
Sep.11, 2013 in
News
The CardioExcyte 96 is a high resolution device recording contractility in intact cardiomyocyte networks utilizing non-invasive impedance measurements. The system allows cost-efficient, early compound safety profiling using stem cell-derived cardiomyocytes, freshly dissociated cardiomyocytes or beating 3D-cell clusters.
Comments Off on Nanion Introduces New Product Family: CardioExcyte 96 for Cardiac Toxicity Profiling and Screening